SGLT Inhibitors in Heart Failure: Benefits Across Diabetes Status and Ejection Fraction
SGLT inhibitors reduce heart failure hospitalizations across ejection fractions and diabetes status, offering broad cardiovascular benefits while producing more modest reductions in mortality.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.